Search results
Postoperative radiotherapy in women with early operable breast cancer (Scottish Breast Conservation Trial): 30-year update of a randomised, controlled, phase 3 trial.
Lancet Oncol, 25(9):1213-1221, 07 Aug 2024
Cited by: 0 articles | PMID: 39127062
Add to export list
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.
J Clin Oncol, 42(24):2887-2898, 02 Jun 2024
Cited by: 0 articles | PMID: 38824432
Add to export list
Geographic variation of mutagenic exposures in kidney cancer genomes.
Nature, 629(8013):910-918, 01 May 2024
Cited by: 6 articles | PMID: 38693263 | PMCID: PMC11111402
Add to export list
Free full text in Europe PMCValidation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients in the TEAM Trial.
Clin Cancer Res, 30(8):1509-1517, 01 Apr 2024
Cited by: 1 article | PMID: 38345755 | PMCID: PMC11016895
Add to export list
Free full text in Europe PMCRecruiting women with ductal carcinoma in situ to a randomised controlled trial: lessons from the LORIS study.
Trials, 24(1):670, 14 Oct 2023
Cited by: 4 articles | PMID: 37838682 | PMCID: PMC10576350
Add to export list
Free full text in Europe PMCSpatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
J Pathol, 260(5):514-532, 23 Aug 2023
Cited by: 2 articles | PMID: 37608771 | PMCID: PMC11288334
Add to export list Review Free full text in Europe PMC
A DNA copy number alteration classifier as a prognostic tool for prostate cancer patients.
Br J Cancer, 128(12):2165-2174, 10 Apr 2023
Cited by: 2 articles | PMID: 37037938 | PMCID: PMC10241891
Add to export list Free full text in Europe PMC
Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.
J Urol, 210(2):257-271, 01 May 2023
Cited by: 0 articles | PMID: 37126232
Add to export list
Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study.
Breast Cancer Res, 24(1):90, 16 Dec 2022
Cited by: 3 articles | PMID: 36527133 | PMCID: PMC9758861
Add to export list
Free full text in Europe PMCSelecting patients with HER2-low breast cancer: Getting out of the tangle.
Eur J Cancer, 175:187-192, 19 Sep 2022
Cited by: 13 articles | PMID: 36137393
Add to export list
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study.
Mod Pathol, 35(10):1362-1369, 21 Jun 2022
Cited by: 12 articles | PMID: 35729220 | PMCID: PMC9514990
Add to export list
Free full text in Europe PMCCorrection: GATA6 Expression Distinguishes Classical and Basal-like Subtypes in Advanced Pancreatic Cancer.
Clin Cancer Res, 28(12):2715, 01 Jun 2022
Cited by: 1 article | PMID: 35694787
Add to export list
Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study.
Clin Cancer Res, 28(9):1871-1880, 01 May 2022
Cited by: 12 articles | PMID: 35144966 | PMCID: PMC9306281
Add to export list
Free full text in Europe PMCDiscordance between Immunohistochemistry and Erb-B2 Receptor Tyrosine Kinase 2 mRNA to Determine Human Epidermal Growth Factor Receptor 2 Low Status for Breast Cancer.
J Mol Diagn, 24(7):775-783, 05 May 2022
Cited by: 12 articles | PMID: 35526835
Add to export list
Incorporation of TILs in daily breast cancer care: how much evidence can we bear?
Virchows Arch, 480(1):147-162, 19 Jan 2022
Cited by: 9 articles | PMID: 35043236
Add to export list Review
Upregulation of IFNɣ-mediated chemokines dominate the immune transcriptome of muscle-invasive urothelial carcinoma.
Sci Rep, 12(1):716, 13 Jan 2022
Cited by: 3 articles | PMID: 35027623 | PMCID: PMC8758674
Add to export list
Free full text in Europe PMCMulti-omic machine learning predictor of breast cancer therapy response.
Nature, 601(7894):623-629, 07 Dec 2021
Cited by: 159 articles | PMID: 34875674 | PMCID: PMC8791834
Add to export list
Free full text in Europe PMCResidual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Lancet Oncol, 23(1):149-160, 11 Dec 2021
Cited by: 130 articles | PMID: 34902335 | PMCID: PMC9455620
Add to export list
Free full text in Europe PMCThe tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group.
NPJ Breast Cancer, 7(1):150, 01 Dec 2021
Cited by: 100 articles | PMID: 34853355 | PMCID: PMC8636568
Add to export list Review
Free full text in Europe PMCInterobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group.
Cancers (Basel), 13(19):4910, 29 Sep 2021
Cited by: 5 articles | PMID: 34638394 | PMCID: PMC8507620
Add to export list
Free full text in Europe PMCHeterogeneity of Circulating Tumor Cell-Associated Genomic Gains in Breast Cancer and Its Association with the Host Immune Response.
Cancer Res, 81(24):6196-6206, 28 Oct 2021
Cited by: 5 articles | PMID: 34711609 | PMCID: PMC9397625
Add to export list
Free full text in Europe PMCCirculating tumor DNA is readily detectable among Ghanaian breast cancer patients supporting non-invasive cancer genomic studies in Africa.
NPJ Precis Oncol, 5(1):83, 17 Sep 2021
Cited by: 4 articles | PMID: 34535742 | PMCID: PMC8448727
Add to export list
Free full text in Europe PMCEvaluation of multiple transcriptomic gene risk signatures in male breast cancer.
NPJ Breast Cancer, 7(1):98, 26 Jul 2021
Cited by: 5 articles | PMID: 34312396 | PMCID: PMC8313692
Add to export list
Free full text in Europe PMCComparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.
NPJ Breast Cancer, 7(1):90, 08 Jul 2021
Cited by: 2 articles | PMID: 34238931 | PMCID: PMC8266887
Add to export list
Free full text in Europe PMCAssessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group.
J Natl Cancer Inst, 113(7):808-819, 01 Jul 2021
Cited by: 244 articles | PMID: 33369635 | PMCID: PMC8487652
Add to export list Review
Free full text in Europe PMC
Follow us
Partnerships & funding
Europe PMC is developed by EMBL-EBI with support from the Europe PMC Funders' Group, in collaboration with the National Library of Medicine (NLM), as part of the PubMed Central International archive network.
Europe PMC is an ELIXIR Core Data Resource, Global Core Biodata Resource, and conforms with EMBL-EBI’s long term data preservation policies.